Your browser doesn't support javascript.
loading
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement.
Skrivankova, Veronika W; Richmond, Rebecca C; Woolf, Benjamin A R; Yarmolinsky, James; Davies, Neil M; Swanson, Sonja A; VanderWeele, Tyler J; Higgins, Julian P T; Timpson, Nicholas J; Dimou, Niki; Langenberg, Claudia; Golub, Robert M; Loder, Elizabeth W; Gallo, Valentina; Tybjaerg-Hansen, Anne; Davey Smith, George; Egger, Matthias; Richards, J Brent.
Afiliação
  • Skrivankova VW; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Richmond RC; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Woolf BAR; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Yarmolinsky J; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Davies NM; Department of Psychological Science, University of Bristol, Bristol, United Kingdom.
  • Swanson SA; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • VanderWeele TJ; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Higgins JPT; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Timpson NJ; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Dimou N; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Norway.
  • Langenberg C; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.
  • Golub RM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Loder EW; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Gallo V; NIHR Bristol Biomedical Research Centre, Bristol, United Kingdom.
  • Tybjaerg-Hansen A; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Davey Smith G; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Egger M; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Richards JB; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
JAMA ; 326(16): 1614-1621, 2021 10 26.
Article em En | MEDLINE | ID: mdl-34698778
ABSTRACT
Importance Mendelian randomization (MR) studies use genetic variation associated with modifiable exposures to assess their possible causal relationship with outcomes and aim to reduce potential bias from confounding and reverse causation.

Objective:

To develop the STROBE-MR Statement as a stand-alone extension to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guideline for the reporting of MR studies. Design, Setting, and

Participants:

The development of the STROBE-MR Statement followed the Enhancing the Quality and Transparency of Health Research (EQUATOR) framework guidance and used the STROBE Statement as a starting point to draft a checklist tailored to MR studies. The project was initiated in 2018 by reviewing the literature on the reporting of instrumental variable and MR studies. A group of 17 experts, including MR methodologists, MR study design users, developers of previous reporting guidelines, and journal editors, participated in a workshop in May 2019 to define the scope of the Statement and draft the checklist. The draft checklist was published as a preprint in July 2019 and discussed on the preprint platform, in social media, and at the 4th Mendelian Randomization Conference. The checklist was then revised based on comments, further refined through 2020, and finalized in July 2021.

Findings:

The STROBE-MR checklist is organized into 6 sections (Title and Abstract, Introduction, Methods, Results, Discussion, and Other Information) and includes 20 main items and 30 subitems. It covers both 1-sample and 2-sample MR studies that assess 1 or multiple exposures and outcomes, and addresses MR studies that follow a genome-wide association study and are reported in the same article. The checklist asks authors to justify why MR is a helpful method to address the study question and state prespecified causal hypotheses. The measurement, quality, and selection of genetic variants must be described and attempts to assess validity of MR-specific assumptions should be well reported. An item on data sharing includes reporting when the data and statistical code required to replicate the analyses can be accessed. Conclusions and Relevance STROBE-MR provides guidelines for reporting MR studies. Improved reporting of these studies could facilitate their evaluation by editors, peer reviewers, researchers, clinicians, and other readers, and enhance the interpretation of their results.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidemiologia / Guias como Assunto / Estudos Observacionais como Assunto / Análise da Randomização Mendeliana / Lista de Checagem Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Qualitative_research / Screening_studies Limite: Humans Idioma: En Revista: JAMA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidemiologia / Guias como Assunto / Estudos Observacionais como Assunto / Análise da Randomização Mendeliana / Lista de Checagem Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Qualitative_research / Screening_studies Limite: Humans Idioma: En Revista: JAMA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça